{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:02:14Z","timestamp":1790596934787,"version":"4.1.0"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013831","name":"Universitatea de Medicin\u0103 \u015fi Farmacie din Craiova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interstitial lung diseases (ILDs) are a heterogeneous group of disorders in which epithelial injury, inflammation and fibrosis lead to progressive loss of lung function. Several ILDs other than idiopathic pulmonary fibrosis (IPF), including connective tissue disease-associated ILD (CTD-ILD), fibrotic hypersensitivity pneumonitis and fibrotic nonspecific interstitial pneumonia, may develop a progressive fibrosing phenotype, and distinguishing fibrotic from non-fibrotic disease is clinically important. Matrix metalloproteinase-7 (MMP-7), a circulating biomarker of extracellular matrix remodeling, epithelial injury and inflammation, has been investigated as a non-invasive marker of fibrosing lung disease, but the evidence remains fragmented and unsynthesized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To summarize current evidence on the diagnostic and prognostic value of MMP-7 in interstitial lung diseases and other chronic respiratory diseases, with particular emphasis on fibrosing lung disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A narrative review was performed using PubMed\/MEDLINE, Scopus and Web of Science. Search terms combined \u201cMMP-7\u201d and \u201cmatrix metalloproteinase-7\u201d with terms for interstitial lung disease, CTD-ILD, fibrotic lung diseases, sarcoidosis, hypersensitivity pneumonitis, progressive pulmonary fibrosis, organizing pneumonia and chronic respiratory diseases. Studies were selected on their evaluation of the diagnostic, prognostic or monitoring role of MMP-7.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and discussion<\/jats:title>\n                    <jats:p>In IPF, MMP-7 shows strong diagnostic and prognostic performance and is associated with disease severity, functional decline and mortality. Elevated levels are consistently reported in CTD-ILD, particularly systemic sclerosis- and rheumatoid arthritis-associated ILD, where they correlate with impaired pulmonary function, radiological fibrosis and disease activity. Increased concentrations have also been described in fibrotic hypersensitivity pneumonitis, fibrotic nonspecific interstitial pneumonia and organizing pneumonia, with conflicting findings in sarcoidosis and chronic obstructive pulmonary disease and limited or predominantly experimental data in asthma and bronchiectasis, where elevation reflects epithelial injury and airway remodeling rather than disease-specific pathology. Across these disorders MMP-7 mirrors shared pathways of epithelial damage and matrix turnover, supporting its potential utility in diagnosis and risk stratification, while its value for monitoring disease activity or treatment response remains unproven.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MMP-7 is best regarded as a marker of active fibrotic remodeling rather than of any single disease, with its clearest value in fibrosing ILD and within multimarker strategies rather than as a standalone test.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1930150","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:40:22Z","timestamp":1790595622000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["MMP-7 as a non-invasive biomarker in interstitial lung diseases and other chronic respiratory diseases: a narrative review"],"prefix":"10.3389","volume":"13","author":[{"given":"Marian Marius","family":"Padureanu","sequence":"first","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Marinescu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, University of Medicine and Pharmacy of Craiova","place":["Craiova, Romania"]},{"name":"Psychiatry Clinic, Craiova Clinical Hospital for Neuropsychiatry","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisa Maria","family":"Mitroi","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu Mihai","family":"Coanda","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Maria","family":"Rosu","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Stefania","family":"Stoica","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihnea Marian","family":"Pomacu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy of Craiova","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionelia Sorina","family":"Stan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy of Craiova","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionela Alina","family":"Croitoru","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Faculty of Medicine, University of Medicine and Pharmacy Carol Davila of Bucharest","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Banicioiu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy of Craiova","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Rosu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy of Craiova","place":["Craiova, Romania"]},{"name":"Rheumatology Research Center, University of Medicine and Pharmacy of Craiova","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viorel","family":"Biciusca","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy of Craiova","place":["Craiova, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"101936","DOI":"10.1016\/J.ECLINM.2023.101936","article-title":"Global burden of chronic respiratory diseases and risk factors, 1990\u20132019: an update from the global burden of disease study 2019","volume":"59","author":"Momtazmanesh","year":"2023","journal-title":"eClinicalMed"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1093\/RHEUMATOLOGY\/KEZ230","article-title":"Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature","volume":"58","author":"Bonhomme","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S10020-025-01128-2\/FIGURES\/7","article-title":"Matrix metalloproteinases and their tissue inhibitors as upcoming biomarker signatures of connective tissue diseases-related interstitial lung disease: towards an earlier and accurate diagnosis","volume":"31","author":"Pulito-Cueto","year":"2025","journal-title":"Mol Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2101560","DOI":"10.1183\/13993003.01560-2021","article-title":"The prognostic role of matrix metalloproteinase-7 in scleroderma-associated interstitial lung disease","volume":"58","author":"Matson","year":"2021","journal-title":"Eur Respir J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.46497\/ARCHRHEUMATOL.2023.9547","article-title":"Clinical association study on the matrix metalloproteinase expression in the serum of patients with connective tissue disease complicated with interstitial lung disease","volume":"38","author":"Chen","year":"2023","journal-title":"Arch Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.3390\/IJMS24043786","article-title":"Matrix metalloproteinases in chronic obstructive pulmonary disease","volume":"24","author":"Christopoulou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/S00726-010-0689-X\/FIGURES\/1","article-title":"Physiology and pathophysiology of matrix metalloproteases","volume":"41","author":"Klein","year":"2011","journal-title":"Amino Acids"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/BS.PMBTS.2017.02.005","article-title":"Biochemical and biological attributes of matrix metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/CELLS9051076","article-title":"Structure and function of human matrix metalloproteinases","volume":"9","author":"Laronha","year":"2020","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/J.CARDIORES.2005.12.002\/2\/M_69-3-562-FIG1.GIF","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"a005058","DOI":"10.1101\/CSHPERSPECT.A005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nrc884","article-title":"Strategies for MMP inhibition in cancer: innovations for the post-trial era","volume":"2","author":"Overall","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/J.MATBIO.2014.04.005","article-title":"Matrilysin\/matrix metalloproteinase-7(MMP7) cleavage of perlecan\/HSPG2 creates a molecular switch to alter prostate cancer cell behavior","volume":"36","author":"Grindel","year":"2014","journal-title":"Matrix Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/153537020623100103","article-title":"Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis","volume":"231","author":"Ii","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0002-9440(10)64318-0\/ASSET\/907F09EB-5A63-4954-8AE4-FC94BF09C92D\/MAIN.ASSETS\/GR9.JPG","article-title":"Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium","volume":"162","author":"McGuire","year":"2003","journal-title":"Am J Pathol"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.5772\/64611","article-title":"Roles of matrix metalloproteinases in cutaneous wound healing","volume-title":"Wound Healing - New Insights into Ancient Challenges","author":"Nguyen","year":"2016"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1020902","DOI":"10.3389\/fimmu.2022.1020902","article-title":"Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein claudin-7","volume":"13","author":"Xiao","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29245\/2689-999x\/2019\/2.1149","article-title":"Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial\/fibroblastic cross-talk","volume":"3","author":"Hill","year":"2019","journal-title":"J Lung Health Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"28823","DOI":"10.1074\/JBC.272.46.28823","article-title":"Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B\/type IV collagenase (MMP-9)","volume":"272","author":"Patterson","year":"1997","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-04199-2","article-title":"Microbial antigens stimulate metalloprotease-7 secretion in human B-lymphocytes using MTOR-dependent and independent pathways","volume":"7","author":"Ali","year":"2017","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.3390\/IJMS23136894","article-title":"Matrix metalloproteinases and their inhibitors in pulmonary fibrosis: eMMPRIN\/CD147 comes into play","volume":"23","author":"Chuli\u00e1-Peris","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/J.RMED.2015.06.003","article-title":"Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias","volume":"109","author":"Morais","year":"2015","journal-title":"Respir Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"24097","DOI":"10.3390\/IJMS141224097","article-title":"MMP-7 and FcDNA serum levels in early NSCLC and idiopathic interstitial pneumonia: preliminary study","volume":"14","author":"Ulivi","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"00553-02024","DOI":"10.1183\/23120541.00553-2024","article-title":"Serum metalloproteinase-7 as a biomarker of progressive pulmonary fibrosis","volume":"10","author":"Ara\u00fajo","year":"2024","journal-title":"ERJ Open Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.3390\/JCM12103564","article-title":"A real-world prognosis in idiopathic pulmonary fibrosis: a special reference to the role of antifibrotic agents for the elderly","volume":"12","author":"Honda","year":"2023","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/MAJ.0B013E31821A9D8E","article-title":"Idiopathic pulmonary fibrosis: a disorder of epithelial cell dysfunction","volume":"341","author":"Zoz","year":"2011","journal-title":"Am J Med Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"16689","DOI":"10.3390\/IJERPH192416689\/S1","article-title":"Prognosis and survival in idiopathic pulmonary fibrosis in the era of antifibrotic therapy in Italy: evidence from a longitudinal population study based on healthcare utilization databases","volume":"19","author":"Iommi","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.3390\/DIAGNOSTICS14232674","article-title":"A practical multidisciplinary approach to identifying interstitial lung disease in systemic autoimmune rheumatic diseases: a clinician\u2019s narrative review","volume":"14","author":"Biciusca","year":"2024","journal-title":"Diagnostics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/S40846-024-00909-0\/TABLES\/1","article-title":"Biomarkers for early diagnosis of idiopathic pulmonary fibrosis: a systematic review","volume":"44","author":"Zhai","year":"2024","journal-title":"J Med Biol Eng"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.3390\/JCM10143167","article-title":"Serum biomarkers in differential diagnosis of idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung disease","volume":"10","author":"Cabrera Cesar","year":"2021","journal-title":"J Clin Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e2024015","DOI":"10.36141\/SVDLD.V41I2.15454","article-title":"The role of biomarkers in the diagnosis and treatment follow-up of idiopathic pulmonary fibrosis","volume":"41","author":"Kayikci","year":"2024","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12964-024-01925-Y","article-title":"The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19","volume":"22","author":"Niayesh-Mehr","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5858\/2009-0144-OA.1","article-title":"Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis","volume":"134","author":"Fujishima","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1165\/RCMB.2015-0020TR","article-title":"Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis","volume":"53","author":"Craig","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2101612","DOI":"10.1183\/13993003.01612-2021","article-title":"A systematic review of blood biomarkers with individual participant data meta-analysis of matrix metalloproteinase-7 in idiopathic pulmonary fibrosis","volume":"59","author":"Khan","year":"2022","journal-title":"Eur Respir J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1378\/chest.11-2735","article-title":"Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis","volume":"143","author":"Song","year":"2013","journal-title":"Chest"},{"key":"B37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/RESP.12920","article-title":"Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis","volume":"22","author":"Tzouvelekis","year":"2017","journal-title":"Respirology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ART.38904","article-title":"Biomarkers of rheumatoid arthritis\u2013associated interstitial lung disease","volume":"67","author":"Chen","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/S00296-016-3636-7\/METRICS","article-title":"Interstitial lung disease in systemic sclerosis: current and future treatment","volume":"37","author":"Giacomelli","year":"2017","journal-title":"Rheumatol Int"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.4172\/1758-4272.1000155","article-title":"Peripheral blood biomarkers in systemic sclerosis-associated interstitial lung diseases","author":"Yu","year":"2018","journal-title":"Int J Clin Rheumatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/ART.42812","article-title":"Plasma matrix metalloproteinase concentrations and risk of interstitial lung disease in a prospective rheumatoid arthritis cohort","volume":"76","author":"Luedders","year":"2024","journal-title":"Arthritis & Rheumatology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"00191-2022","DOI":"10.1183\/23120541.00191-2022","article-title":"Matrix metalloproteinase-7 is increased in lung bases but not apices in idiopathic pulmonary fibrosis","volume":"8","author":"Jaffar","year":"2022","journal-title":"ERJ Open Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1371\/JOURNAL.PMED.0050093","article-title":"MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis","volume":"5","author":"Rosas","year":"2008","journal-title":"PLoS Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/J.RESINV.2020.07.003","article-title":"Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis","volume":"58","author":"Isshiki","year":"2020","journal-title":"Respir Investig"},{"key":"B45","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1164\/RCCM.200803-490OC","article-title":"Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis","volume":"179","author":"Crouser","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1164\/RCCM.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1378\/CHEST.07-2116","article-title":"Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?","volume":"133","author":"Huh","year":"2008","journal-title":"Chest"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1164\/RCCM.201505-0862OC","article-title":"Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias","volume":"194","author":"White","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1515\/BJMG-2017-0023","article-title":"Association of the MMP7 -181A\u2009>\u2009G promoter polymorphism with early onset of chronic obstructive pulmonary disease","volume":"20","author":"Tacheva","year":"2017","journal-title":"Balkan J Med Genet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12931-020-01496-9\/FIGURES\/2","article-title":"Value of metalloproteinases in predicting COPD in heavy urban smokers","volume":"21","author":"Tsay","year":"2020","journal-title":"Respir Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/NU16121851\/S1","article-title":"Integrative approach to risk factors in simple chronic obstructive airway diseases of the lung or associated with metabolic syndrome-analysis and prediction","volume":"16","author":"Streba","year":"2024","journal-title":"Nutrients"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.3390\/JCM14134633","article-title":"Beyond smoking: emerging drivers of COPD and their clinical implications in low- and middle-income countries: a narrative review","volume":"14","author":"Cioboata","year":"2025","journal-title":"J Clin Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/RR33","article-title":"Matrix metalloproteinases in lung biology","volume":"2","author":"Parks","year":"2001","journal-title":"Respir Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"190124","DOI":"10.1183\/16000617.0124-2019","article-title":"Extracellular matrix remodelling in COPD","volume":"29","author":"Karakioulaki","year":"2020","journal-title":"Eur Respir Rev"},{"key":"B55","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1183\/09031936.00121611","article-title":"Matrix metalloproteinases in COPD","volume":"39","author":"Churg","year":"2012","journal-title":"Eur Respir J"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-32216-0","article-title":"A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD","volume":"13","author":"DiLillo","year":"2023","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-15-74","article-title":"FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure","volume":"15","author":"Monta\u00f1o","year":"2014","journal-title":"Respir Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1152\/PHYSREV.00022.2006\/ASSET\/IMAGES\/LARGE\/Z9J0010724210006.JPEG","article-title":"Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted","volume":"87","author":"Greenlee","year":"2007","journal-title":"Physiol Rev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e46207","DOI":"10.1371\/JOURNAL.PONE.0046207","article-title":"Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum","volume":"7","author":"R\u00f6pcke","year":"2012","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0092-8674(02)01079-6","article-title":"Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury","volume":"111","author":"Li","year":"2002","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/MI.2013.76\/ATTACHMENT\/3A88ACCC-6B73-4A62-9B00-2E8DEE6B7D13\/MMC7.PPT","article-title":"Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation","volume":"7","author":"Vandenbroucke","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1186\/S12931-015-0225-3","article-title":"Accelerated extracellular matrix turnover during exacerbations of COPD","volume":"16","author":"Sand","year":"2015","journal-title":"Respir Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"16042","DOI":"10.3390\/IJMS242216042","article-title":"Bronchial asthma, airway remodeling and lung fibrosis as successive steps of one process","volume":"24","author":"Savin","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B64","first-page":"113","article-title":"The advance of personalized and stratified therapies in bronchial asthma: phenotypes \u2013 endotypes \u2013 biomarkers","volume":"24","author":"Lauer","year":"2014","journal-title":"EJIFCC"},{"key":"B65","doi-asserted-by":"publisher","first-page":"100368","DOI":"10.1016\/J.OPRESP.2024.100368","article-title":"Personalized medicine in severe asthma: bridging the gaps","volume":"6","author":"Garc\u00eda-Rivero","year":"2024","journal-title":"Open Respiratory Archives"},{"key":"B66","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/NI.1719","article-title":"Divergent roles for airway epithelial MMP7 and retinoic acid in experimental asthma","volume":"10","author":"Goswami","year":"2009","journal-title":"Nat Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2020.00191","article-title":"Airway remodeling in asthma","author":"Hough","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/J.COPH.2010.06.004","article-title":"Airway remodeling in Asthma","volume":"10","author":"Halwani","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6645072","article-title":"Role of matrix metalloproteinases in angiogenesis and its implications in asthma","volume":"2021","author":"Bajbouj","year":"2021","journal-title":"J Immunol Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/2040622315609251","article-title":"Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease","volume":"7","author":"George","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"B71","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.4049\/JIMMUNOL.177.10.7312","article-title":"Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation","volume":"177","author":"Greenlee","year":"2006","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/J.JACI.2020.04.010\/ASSET\/B1A47E96-E6B8-43AA-9E4F-F0B3722C0F2B\/MAIN.ASSETS\/GR4.JPG","article-title":"Epithelial barriers in allergy and asthma","volume":"145","author":"Hellings","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/J.JACI.2013.03.005\/ASSET\/0D7EA857-B2C2-42B2-BFCB-E901DB1F3D5C\/MAIN.ASSETS\/FX5.JPG","article-title":"TNF-\u03b1-mediated bronchial barrier disruption and regulation by Src-family kinase activation","volume":"132","author":"Hardyman","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"107144","DOI":"10.1016\/J.PHRS.2024.107144","article-title":"The role of epithelial cells in fibrosis: mechanisms and treatment","volume":"202","author":"Luo","year":"2024","journal-title":"Pharmacol Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4168\/AAIR.2024.16.5.462","article-title":"Update on inflammatory biomarkers for defining asthma phenotype","volume":"16","author":"Sim","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/S12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"104936","DOI":"10.1016\/J.EBIOM.2023.104936\/ATTACHMENT\/0F070264-245E-4273-9EB9-D6440DBC5413\/MMC2.XLSX","article-title":"Proteomic signatures of eosinophilic and neutrophilic asthma from serum and sputum","volume":"99","author":"Asamoah","year":"2024","journal-title":"EBioMedicine"},{"key":"B78","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jaip.2023.01.006","article-title":"Blood eosinophil and neutrophil categories can differentiate adult asthma phenotypes","volume":"11","author":"Rupani","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B79","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/COPD.S6133","article-title":"The pathophysiology of bronchiectasis","volume":"4","author":"King","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"104174","DOI":"10.1016\/J.LPM.2023.104174","article-title":"Bronchiectasis","volume":"52","author":"Barbosa","year":"2023","journal-title":"Presse Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"230015","DOI":"10.1183\/16000617.0015-2023","article-title":"Basic, translational and clinical aspects of bronchiectasis in adults","volume":"32","author":"Chalmers","year":"2023","journal-title":"Eur Respir Rev"},{"key":"B82","doi-asserted-by":"publisher","first-page":"240179","DOI":"10.1183\/16000617.0179-2024","article-title":"Neutrophilic inflammation in bronchiectasis","volume":"34","author":"Chalmers","year":"2025","journal-title":"Eur Respir Rev"},{"key":"B83","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1513\/ANNALSATS.201411-513OC","article-title":"Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis","volume":"12","author":"Taylor","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"B84","doi-asserted-by":"publisher","first-page":"230234","DOI":"10.1183\/16000617.0234-2023","article-title":"Biomarkers in bronchiectasis","volume":"33","author":"Johnson","year":"2024","journal-title":"Eur Respir Rev"},{"key":"B85","doi-asserted-by":"publisher","first-page":"10546","DOI":"10.3390\/IJMS231810546","article-title":"The role of matrix metalloproteinase in inflammation with a focus on infectious diseases","volume":"23","author":"Lee","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/J.CMI.2019.07.010","article-title":"How does pseudomonas aeruginosa affect the progression of bronchiectasis?","volume":"26","author":"Chai","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B87","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.rmed.2019.06.012","article-title":"Mucoid pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis","volume":"154","author":"Alcaraz-Serrano","year":"2019","journal-title":"Respir Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1128\/IAI.00799-07","article-title":"Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with pseudomonas aeruginosa","volume":"75","author":"Kassim","year":"2007","journal-title":"Infect Immun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1164\/rccm.201701-0254OC","article-title":"Serum matrix metalloproteinase-7, respiratory symptoms, and mortality in community-dwelling adults MESA (multi-ethnic study of atherosclerosis)","volume":"196","author":"Armstrong","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/RESP.14894","article-title":"Pre-treatment MMP7 predicts progressive idiopathic pulmonary fibrosis in antifibrotic treated patients","volume":"30","author":"Li","year":"2025","journal-title":"Respirology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"00074-2016","DOI":"10.1183\/23120541.00074-2016","article-title":"MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis","volume":"3","author":"Bauer","year":"2017","journal-title":"ERJ Open Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4759040","article-title":"Comparative study of circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as disease markers of idiopathic pulmonary fibrosis","volume":"2016","author":"Hamai","year":"2016","journal-title":"Dis Markers"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-022-09283-W","article-title":"Blood KL-6 predicts prognosis in primary sj\u00f6gren\u2019s syndrome-associated interstitial lung disease","author":"Kim","year":"2022","journal-title":"Sci Rep."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1183\/13993003\/ERJ.42.SUPPL_57.P5129","article-title":"KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases","author":"Ishikawa","year":"2013","journal-title":"Eur Respir J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.3390\/JCM10173864\/S1","article-title":"Serial measurements of circulating Kl-6, Sp-d, Mmp-7, Ca19-9, ca-125, Ccl18, and periostin in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy: an exploratory study","volume":"10","author":"Majewski","year":"2021","journal-title":"J Clin Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","article-title":"Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes","volume":"17","author":"Winer","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/BIOMEDICINES13071581","article-title":"Inhibition of matrix metalloproteinase-7 attenuates subpleural fibrosis in rheumatoid arthritis-associated interstitial lung disease","volume":"13","author":"Xiong","year":"2025","journal-title":"Biomedicines"},{"key":"B98","doi-asserted-by":"publisher","first-page":"009","DOI":"10.29328\/journal.jprr.1001067","article-title":"Post-COVID pulmonary fibrosis: pathophysiological mechanisms, diagnostic tools, and emerging therapies","volume":"9","author":"Sabu","year":"2025","journal-title":"Journal of Pulmonology and Respiratory Research"},{"key":"B99","doi-asserted-by":"publisher","first-page":"00266-2024","DOI":"10.1183\/23120541.00266-2024","article-title":"Matrix metalloprotease-7 is associated with post-COVID-19 persistent lung abnormalities","volume":"10","author":"Buendia-Roldan","year":"2024","journal-title":"ERJ Open Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1930150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:40:25Z","timestamp":1790595625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1930150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":99,"alternative-id":["10.3389\/fmed.2026.1930150"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1930150","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1930150"}}